Intraclox DC, intramaminė suspensija galvijams
Intraclox DC, intramaminė suspensija galvijams
Authorised
- Cloxacillin
Product identification
Medicine name:
Intraclox DC, intramaminė suspensija galvijams
Active substance:
- Cloxacillin
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin500.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal28dayNot authorized for use in cattle, 35 days before calving.
-
Milk108hourFor human consumption, milk can be used only after 108 hours after calfing. If the cow calved 35 days before last treatment, their milk can be used for human consumption only after 35 days and 108 hours after last treatment. If the cow has hypocalcemia, the withdrawal period may be longer.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Interchemie werken De Adelaar LT UAB
Marketing authorisation date:
Manufacturing sites for batch release:
- Interchemie Werken De Adelaar Eesti AS
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/20/2593/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Lithuanian (PDF)
Published on: 23/12/2025
